4TYO
PPIase in complex with a non-phosphate small molecule inhibitor.
4TYO の概要
| エントリーDOI | 10.2210/pdb4tyo/pdb |
| 関連するPDBエントリー | 3I6C 3IK8 3IKD 3IKG 3JYJ |
| 分子名称 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1, 3-(6-fluoro-1H-benzimidazol-2-yl)-N-(naphthalen-2-ylcarbonyl)-D-alanine, GLYCEROL, ... (4 entities in total) |
| 機能のキーワード | sbdd, ppiase, cell cycle, isomerase, small molecule, nucleus, phosphoprotein, rotamase, peptidyl-prolyl cis-trans isomerase, isomerase-isomerase inhibitor complex, isomerase/isomerase inhibitor |
| 由来する生物種 | Homo sapiens (Human) |
| 細胞内の位置 | Nucleus : Q13526 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 28263.32 |
| 構造登録者 | |
| 主引用文献 | Guo, C.,Hou, X.,Dong, L.,Marakovits, J.,Greasley, S.,Dagostino, E.,Ferre, R.,Catherine Johnson, M.,Humphries, P.S.,Li, H.,Paderes, G.D.,Piraino, J.,Kraynov, E.,Murray, B.W. Structure-based design of novel human Pin1 inhibitors (III): Optimizing affinity beyond the phosphate recognition pocket. Bioorg.Med.Chem.Lett., 24:4187-4191, 2014 Cited by PubMed Abstract: The design of potent Pin1 inhibitors has been challenging because its active site specifically recognizes a phospho-protein epitope. The de novo design of phosphate-based Pin1 inhibitors focusing on the phosphate recognition pocket and the successful replacement of the phosphate group with a carboxylate have been previously reported. The potency of the carboxylate series is now further improved through structure-based optimization of ligand-protein interactions in the proline binding site which exploits the H-bond interactions necessary for Pin1 catalytic function. Further optimization using a focused library approach led to the discovery of low nanomolar non-phosphate small molecular Pin1 inhibitors. Structural modifications designed to improve cell permeability resulted in Pin1 inhibitors with low micromolar anti-proliferative activities against cancer cells. PubMed: 25091930DOI: 10.1016/j.bmcl.2014.07.044 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.75 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






